243 related articles for article (PubMed ID: 18716850)
1. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.
Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N
J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850
[TBL] [Abstract][Full Text] [Related]
2. MGMT-B gene promoter hypermethylation in patients with inflammatory bowel disease - a novel finding.
Mokarram P; Kavousipour S; Sarabi MM; Mehrabani G; Fahmidehkar MA; Shamsdin SA; Alipour A; Naini MA
Asian Pac J Cancer Prev; 2015; 16(5):1945-52. PubMed ID: 25773792
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
[TBL] [Abstract][Full Text] [Related]
4. Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study.
Beggs AD; Mehta S; Deeks JJ; James JD; Caldwell GM; Dilworth MP; Stockton JD; Blakeway D; Pestinger V; Vince A; Taniere P; Iqbal T; Magill L; Matthews G; Morton DG;
EBioMedicine; 2019 Jan; 39():265-271. PubMed ID: 30473377
[TBL] [Abstract][Full Text] [Related]
5. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists.
Silva AL; Dawson SN; Arends MJ; Guttula K; Hall N; Cameron EA; Huang TH; Brenton JD; Tavaré S; Bienz M; Ibrahim AE
BMC Cancer; 2014 Nov; 14():891. PubMed ID: 25432628
[TBL] [Abstract][Full Text] [Related]
6. WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance.
Claessen MM; Schipper ME; Oldenburg B; Siersema PD; Offerhaus GJ; Vleggaar FP
Cell Oncol; 2010 Jan; 32(4):303-10. PubMed ID: 20208143
[TBL] [Abstract][Full Text] [Related]
7. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
Chim CS; Pang R; Liang R
J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
Chim CS; Pang R; Fung TK; Choi CL; Liang R
Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
[TBL] [Abstract][Full Text] [Related]
12. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients.
Salama RH; Sayed ZEA; Ashmawy AM; Elsewify WA; Ezzat GM; Mahmoud MA; Alsanory AA; Alsanory TA
Appl Biochem Biotechnol; 2019 Sep; 189(1):330-343. PubMed ID: 30989570
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.
Román-Gómez J; Cordeu L; Agirre X; Jiménez-Velasco A; San José-Eneriz E; Garate L; Calasanz MJ; Heiniger A; Torres A; Prosper F
Blood; 2007 Apr; 109(8):3462-9. PubMed ID: 17148581
[TBL] [Abstract][Full Text] [Related]
14. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.
Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G
Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.
Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055
[TBL] [Abstract][Full Text] [Related]
16. WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.
Serafino A; Moroni N; Zonfrillo M; Andreola F; Mercuri L; Nicotera G; Nunziata J; Ricci R; Antinori A; Rasi G; Pierimarchi P
Oncotarget; 2014 Feb; 5(4):978-92. PubMed ID: 24657851
[TBL] [Abstract][Full Text] [Related]
17. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J
Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB
World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD
Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.
Licchesi JD; Westra WH; Hooker CM; Machida EO; Baylin SB; Herman JG
Carcinogenesis; 2008 May; 29(5):895-904. PubMed ID: 18308762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
